          |
 |
2003 Abstracts and Meeting Agenda Scientific
Session Moderator: Regis P. Kowalski 7:00 a.m. Registration (Rotunda) 7:30 a.m. Abs.#
1 The In-Vitro Evaluation of the Ophthalmic Fluoroquinolones Against
Bacterial Conjunctivitis Isolates 7:37 a.m. Abs.#
2: In-Vitro Susceptibility and Minimal Inhibitory Concentration
Data for Ocular Pathogens for Gatifloxacin in Comparison With 4
Other Fluoroquinolones 7:44 a.m. Abs.#
3: The Successful Treatment of Gatifloxacin-Resistant Staphylococcus
aureus Keratitis with Gatifloxacin (Zymar) in a NZW Rabbit Model 7:51 a.m. Abs.#
4 In -Vitro Resistant Rates for Fluoroquinolones Against Methicillin-Sensitive
(MS) and Methicillin Resistant (MR) Staphylococcus aureus Ocular
Isolates 7:58 a.m. Abs.#
5: Do Flies Transmit Trachoma? 8:05 a.m. Abs.#
6: Elimination May Not Be Too High a Goal For Trachoma Programs 8:12 a.m. Abs.#
7: Pseudomonas Radial Keratoneuritis 8:19 a.m. Abs#
8: Serratia Corneal Ulcers: A Retrospective Clinical Study 8:26 a.m. Abs.#
9: The Effect of Cataract Surgery on Antibiotic Ocular Penetration 8:33 a.m. Abs.#
10: Human Aqueous Humor Penetration Pharmacokinetics of Moxifloxacin
After Topical Administration of Moxifloxacin 0.5% Ophthalmic Solution 8:40 a.m. Abs.#
11: The Prevention of Bacterial Endophthalmitis by Topical Moxifloxacin
in a Rabbit Prophylaxis Model 8:47 a.m. Abs.#
12: Intraocular Safety of Gatifloxacin in a Rabbit Model 8:54 a.m. Abs.#
13: Fungal Colonization of Keratoprosthesis 9:01 a.m. Abs.#
14: Will Voriconazole Become the Antifungal of Choice in the Treatment
of Corneal Yeast Infection? 9:08 a.m. Abs.#
15: Comparison of Fungal Contamination in Benzalkonium Chloride
(BAK) Preserved and BAK Free Fluoroquinolone Antibiotics 9:15 a.m. Abs.#
16: The Antimicrobial Preservative Efficacy of Zymar and Vigamox
Against Yeast Isolates 9:22 a.m. Abs.#
17: Ocular Surface Squamous Neoplasia: The Standard of Care Survey 9:29 a.m. Abs.#
18: The Microbial Flora From Explanted Punctal Plugs 9:36 a.m. Abs.#
19: The Reliability of Transport Medium for Corneal Ulcer Culture
and Microbiological Investigations: A Clinical Comparison with Direct
Plate Inoculation 9:43 a.m. Abs.#
20: Microbial Keratitis After Amniotic Membrane Grafting (AMG) 9:50 a.m. Abs.#
21: The Threat of Atypical Mycobacteria in Ophthalmology 9:57 a.m. Abs.#
22: Effectiveness of Fluoroquinolone Antibiotics for Experimental
Mycobacterium chelonae Keratitis 10:04 a.m. Abs.#
23: Expression Profile of Transcriptional Regulators in Cornea in
a Mouse Model of Infectious Keratitis 10:11 a.m. Abs.#
24: Safety of Prophylactic Intracameral Gatifloxacin in Cataract
Surgery 10:17 a.m. THYGESON
LECTURE - Richard K. Forster, M.D. 10:42 a.m. Closing Comments and Awards 10:45 a.m. END
|
|
